MicroPort Scientific Corporation released its FF301 Monthly Return for the period ended 31 July 2026. Key points are as follows:

1. Share capital stability • Authorised capital remained at 5.00 billion ordinary shares with an aggregate par value of USD 50,000. • Issued shares were unchanged at 1.92 billion. The company continued to hold zero treasury shares. • Public float exceeded the 25 % requirement under Main Board Rule 13.32B.

2. Equity incentive pools • 2010 Share Option Scheme: 41.21 million options outstanding; all remain unexercised. • 2020 Share Option Scheme: 64.00 million options outstanding, with capacity for 52.82 million share issuances. • 2023 Share Scheme: 35.83 million options outstanding; 19.07 million shares available for grant and a further 144.93 million authorised for future issuance. No options were exercised during the month, resulting in zero new shares issued and no cash proceeds.

3. Outstanding convertibles • 5.75 % Convertible Bonds due 2028: USD 220.00 million outstanding, convertible into up to 134.54 million shares at HKD 12.779 per share. • Convertible Loan Facility (5.75 %): USD 158.50 million drawn, carrying a conversion price of HKD 7.46 and exchangeable for up to 166.33 million shares. No conversions occurred in July.

4. Absence of other equity movements The company reported no warrants, HDR activity, share repurchases, or other share‐related transactions during the month.

MicroPort’s static share count, coupled with sizeable outstanding equity incentives and USD 378.50 million in convertible instruments, signals potential dilution capacity of more than 300 million shares, although no such events materialised in July 2026.